Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, MIN

Dr. Keith Ablow Releases Flagship Website, www.KeithAblow.com


BOSTON, March 10, 2022 /PRNewswire/ -- Dr. Keith Ablow, the New York Times bestselling author, life/leadership coach and business consultant, has released his flagship website, www.keithablow.com. The new website showcases the range of Dr. Ablow's services, including his Pinnacle Leadership Program, Synergy Coaching Program and Mental Health Reset Program. The range of these services tap directly into Dr. Ablow's long experience as a psychiatrist, entrepreneur, political consultant and journalist.

"I wanted to assemble the full range of services that I am grateful to be sharing with clients under one roof, if you will," Dr. Keith Ablow said. "That's what www.keithablow.com is all about. It is meant to be an easily-navigated guide to accessing the kind of help which each individual or company truly needs?from leading a large company through turbulent times, to starting a new company from scratch, to becoming the strongest person an individual can possibly be. I believe that this site accomplishes that."

Dr. Keith Ablow has consulted to individuals and organizations around the world, including Fortune 500 CEOs, elected officials, authors, artists, entrepreneurs and men and women from every walk of life. He is the author of 16 bestselling books, published in several languages by leading American publishers, including Simon & Schuster, Random House and Little, Brown and Company. He has appeared over 1,000 times on national broadcasts covering topics in psychology, business and politics, including the Today Show, Good Morning America, Oprah, 20/20, Dr. Oz, Fox & Friends, Inside Edition and CBS This Morning. His work has been praised by luminaries including the late Pulitzer Prize-winning author William Styron (Sophie's Choice) and many others.

Dr. Ablow founded the Pain-2-Power Life Coaching and Consulting platform (www.pain-2-power.com) during 2019.  He is also the co-founder of www.Help22.org, a 501C3 not-for-profit organization dedicated to helping to reduce veteran suicide. He was the co-founder, with the late Drew Lewis, Ronald Reagan's Secretary of Transportation, of The Gentleman's Partnership, which raised over $1M to help women in crisis. 

"I can't emphasize enough how gratifying it has been to help those who have found resources on www.Pain-2-Power.com and who have then reached out for my 1:1 assistance and synergy," Dr. Ablow said. "Because of our wonderful growth over these few years, a new flagship site was needed, in order to present the full range of what I am pleased to offer my clients. Growth is good?especially when accompanied by clarity of purpose and planning."

Media Contact:
TIffany Bartholomew
978.462.1125
[email protected]

SOURCE Dr. Keith Ablow


These press releases may also interest you

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

18 mai 2024
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: